A pyridinyl bisphosphonate drug, used for the treatment or prevention of osteoporosis in men and women. Risedronate helps in inhibiting the osteoclast-mediated bone resorption and modulates bone metabolism. An aminobisphosphonate derivative of etidronic acid. Reference standards of Risedronate Sodium API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Risedronate Sodium (IPRS/66/13)-from IPC [catalogue_number] => PA IPIPRS 66 13 [category_ids] => ,151, [chemical_name] => [weight] => NA [form] => [cas] => NA [pslug] => risedronate-sodium-iprs-66-13-paipiprs6613 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA IPIPRS 66 13
CAS :
Molecular Formula :
Molecular Weight : NA
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....